| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc42afc59a9fc52e3eb38ba873eb424d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f579cf2494f8d6adfbd028871fd4bca4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a613c9c1d156891fb2254144f996d8da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17e4381cdb1e931246fca837db61ff37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f13ca380547c5ffaec352c8117fb465e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08a5dcf6167350aa3b6c25e49f7c9759 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2009-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_931e4c1dac6a564e7e58daaf41d888f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71debd54cbd47e3b190537cb4dddc70b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47edc199e7a2b4b1f9d6ebc79d6a308b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9870cd80b276437018471c1afab2127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1283117f1c11eaf9e2852cd6f8c24c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67734aaa79d4ff6cb1be99a70b9fd930 |
| publicationDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010068191-A1 |
| titleOfInvention |
Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions |
| abstract |
One or more purified mesenchymal stem cell pharmaceutical compositions and methods of manufacture utilizing centrifugal filtration are disclosed. Threshold limits for intravenous administration of mesenchymal stem cell pharmaceutical compositions comprising residual animal products are also disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015030571-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9963678-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012048093-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2318519-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11708560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020231968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10104880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828586-B2 |
| priorityDate |
2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |